pharmaceuticals-and-healthcare

United States Drugs for Malaria Market Report 2022


Published On : Mar 2017

Category : Pharmaceutical

No. of Pages : 122 pages

  • $3800
  • $7600

Please click below to avail discount on this report

alaria remains one of the most devastating infectious diseases with approximately 212 million infections and 429,000 deaths each year. In 2016, the revenue is 33.8 M USD.

This report studies sales (consumption) of drugs for malaria in USA market, focuses on top players, with revenue, gross margin and market share for each player, covering
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

Split by product types, with revenue, market share and growth rate of each type, can be divided into
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds

Split by applications, this report focuses on revenue, market share and growth rate of drugs for malaria in each application, can be divided into
Prevention
Treatment
Other






In the recent times, the global market for United states drugs for malaria market report 2022 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states drugs for malaria market report 2022 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states drugs for malaria market report 2022 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states drugs for malaria market report 2022 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states drugs for malaria market report 2022 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states drugs for malaria market report 2022, including the definition, classification, and industry chain structure of United states drugs for malaria market report 2022, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states drugs for malaria market report 2022.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states drugs for malaria market report 2022 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states drugs for malaria market report 2022, implemented in each of the geographical segments. The predominant applications of the United states drugs for malaria market report 2022 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states drugs for malaria market report 2022 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states drugs for malaria market report 2022 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Drugs for Malaria1
Table Classification of Drugs for Malaria2
Table United States Drugs for Malaria Revenue Share by Types (2015-2016)2
Figure United States Revenue Market Share of Drugs for Malaria by Types in 20163
Figure Aryl Aminoalcohol Compounds Picture4
Figure Antifolate Compounds Picture5
Figure Artemisinin Compounds Picture6
Table Applications of Drugs for Malaria6
Table United States Drugs for Malaria Revenue Market Share by Applications (2015-2016)7
Figure United States Revenue Market Share of Drugs for Malaria by Applications in 20168
Figure Prevention Examples9
Figure Treatment Examples9
Figure Malaria Deaths Averted, 2001-201312
Table Joint Goals, Milestones and Targets for 2016-203014
Figure United States Drugs for Malaria Revenue and Growth Rate (2011-2022)15
Table United States Drugs for Malaria Revenue by Manufacturers (2015 and 2016)16
Table United States Drugs for Malaria Revenue Share by Manufacturers (2015 and 2016)16
Figure 2015 United States Drugs for Malaria Revenue Share by Manufacturers17
Figure 2016 United States Drugs for Malaria Revenue Share by Manufacturers18
Table 2016 United States Drugs for Malaria Revenue Share by Manufacturers19
Figure 2016 Drugs for Malaria Revenue Market Share of Top 3 Manufacturers20
Figure 2016 Drugs for Malaria Revenue Market Share of Top 5 Manufacturers20
Table Mergers & Acquisitions, Expansion21
Table United States Drugs for Malaria Revenue (M USD) by Types (2011-2016)28
Table United States Drugs for Malaria Revenue Share by Types (2011-2016)28
Figure Revenue Market Share of Drugs for Malaria by Types (2011-2016)29
Figure 2011 Revenue Market Share of Drugs for Malaria by Types29
Figure 2012 Revenue Market Share of Drugs for Malaria by Types30
Figure 2013 Revenue Market Share of Drugs for Malaria by Types31
Figure 2014 Revenue Market Share of Drugs for Malaria by Types32
Figure 2015 Revenue Market Share of Drugs for Malaria by Types33
Figure 2016 Revenue Market Share of Drugs for Malaria by Types34
Figure United States Drugs for Malaria Revenue Growth Rate by Types (2012-2016)35
Table United States Drugs for Malaria Revenue by Applications (2011-2016)36
Table United States Drugs for Malaria Revenue Market Share by Applications (2011-2016)36
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201137
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201238
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201339
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201440
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201541
Figure United States Drugs for Malaria Revenue Market Share by Applications in 201642
Table United States Drugs for Malaria Revenue Growth Rate by Applications (2012-2016)42
Figure United States Drugs for Malaria Revenue Growth Rate by Applications (2012-2016)43
Table Market Drivers43
Table Cipla Basic Information List45
Figure Drugs for Malaria Product Information46
Table Cipla Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)47
Table Guilin Pharmaceutical Basic Information List48
Table Drugs for Malaria Product Information49
Table Guilin Pharmaceutical Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)51
Table IPCA Laboratories Basic Information List53
Figure Drugs for Malaria Product Information54
Table IPCA Laboratories Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)55
Table GlaxoSmithKline Basic Information List56
Table Drugs for Malaria Product Information57
Table GlaxoSmithKline Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)58
Table Mylan Labs Basic Information List59
Table Drugs for Malaria Product Information60
Table Mylan Labs Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)60
Table Roche Basic Information List61
Table Drugs for Malaria Product Information62
Table Roche Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)63
Table Novartis Basic Information List65
Table Drugs for Malaria Product Information66
Table Novartis Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)67
Table Sanofi Aventis Basic Information List68
Table Drugs for Malaria Product Information69
Table Sanofi Aventis Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)70
Table Ajanta Pharma Basic Information List71
Table Drugs for Malaria Product Information72
Table Ajanta Pharma Drugs for Malaria Revenue, Cost, Gross and Gross Margin (2015-2016)73
Table Picture of Raw Materials76
Figure Price Trend of Artemisinin 2013-201678
Table Key Suppliers of Raw Materials78
Figure Market Concentration Rate of Artemisinin81
Figure Manufacturing Cost Structure of Drugs for Malaria81
Figure United States Overview of Average Hourly Wages 2015-2016 (USD/Hour)82
Figure United States Overview of Labor Costs 2013-2016 (110 Index Points)83
Figure Cost of Employing a Factory Worker85
Table Average Price of Electricity to Ultimate Customers86
Figure Manufacturing Process Analysis of Drugs for Malaria88
Figure Drugs for Malaria Industrial Chain Analysis89
Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 201690
Table Major Buyers of Drugs for Malaria91
Table Distributors/Traders List96
Figure Global GDP Growth Rate for 2015101
Figure United States GDP 2006-2016 (Billion USD)102
Figure United States CPI Change 2016-2017102
Figure United States Drugs for Malaria Revenue and Growth Rate Forecast (2017-2022)103
Table United States Drugs for Malaria Revenue Forecast by Types (2017-2022)103
Table United States Drugs for Malaria Revenue Share Forecast by Types (2017-2022)104
Table United States Drugs for Malaria Revenue Forecast by Application (2017-2022)104
Table United States Drugs for Malaria Revenue Share Forecast by Application (2017-2022)105

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top